Showing results (11-20 of 34) with videos related to
Sort By:
Pageof 4
European Journal of Immunology|February 13, 2001
CD4+Ki67+ lymphocytes in HIV-infected patients are effector T cells accumulated in the G1 phase of the cell cycleB Combadère, C Blanc, T Li, et al.Antimicrobial Agents and Chemotherapy|February 22, 2001
Prevalence and conditions of selection of E44D/A and V118I human immunodeficiency virus type 1 reverse transcriptase mutations in clinical practiceC Delaugerre, M Mouroux, A Yvon-Groussin, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 9, 2020
Phylogenetic investigation of HCV-4d epidemic in Paris MSM HIV population reveals a still active outbreak and a strong link to the NetherlandsB Visseaux, S Hué, Q Le Hingrat, et al.Tropical Medicine & International Health : TM & IH|July 31, 2018
HIV-1 drug resistance testing at second-line regimen failure in Arua, Uganda: avoiding unnecessary switch to an empiric third-lineF Fily, E Ayikobua, D Ssemwanga, et al.HIV Medicine|May 10, 2013
An undetectable polymerase chain reaction signal in routine HIV plasma viral load monitoring is associated with better virological outcomes in patients receiving highly active antiretroviral therapyP Pugliese, C Delpierre, L Cuzin, et al.British Journal of Clinical Pharmacology|February 28, 2007
Age-related differences in the pharmacokinetics of stavudine in 272 children from birth to 16 years: a population analysisV Jullien, A Raïs, S Urien, et al.The Journal of Antimicrobial Chemotherapy|October 27, 2014
Archived HIV-1 DNA resistance mutations to rilpivirine and etravirine in successfully treated HIV-1-infected individuals pre-exposed to efavirenz or nevirapineS Gallien, I Charreau, M L Nere, et al.The Journal of Antimicrobial Chemotherapy|September 18, 2014
HIV-1 subtype influences susceptibility and response to monotherapy with the protease inhibitor lopinavir/ritonavirK A Sutherland, J Ghosn, J Gregson, et al.HIV Medicine|March 16, 2012
Comparison of resistance mutation patterns in historical plasma HIV RNA genotypes with those in current proviral HIV DNA genotypes among extensively treated patients with suppressed replicationC Delaugerre, J Braun, I Charreau, et al.Journal of Viral Hepatitis|April 17, 2018
Precore G1896A mutation is associated with reduced rates of HBsAg seroclearance in treated HIV hepatitis B virus co-infected patients from Western AfricaA Boyd, R Moh, S Maylin, et al.Pageof 4